Banned cancer drugs better than NHS ones
One drug for kidney cancer, routinely available through public health systems in most European countries but not to British patients, can reduce the size of tumours in 31% of patients, compared with just 6% of those prescribed the standard NHS drug. Full Story
~~~~~~~~
ADS!
~~~~~~~~
~~
0 commenti:
Post a Comment